Literature DB >> 19944224

Tetrandrine ameliorated reperfusion injury of small bowel transplantation.

Yun Chen1, Jiann-Ming Wu, Tzu-Yu Lin, Chia-Chan Wu, Kuan-Ming Chiu, Bee-Feng Chang, Sheng-Hong Tseng, Shu-Hsun Chu.   

Abstract

PURPOSE: In small bowel transplantation, the bowel graft is susceptible to reperfusion injury. This study investigated the effects of tetrandrine, a bisbenzylisoquinoline alkaloid, on the development of intestinal reperfusion injury in small bowel transplantation in pigs.
MATERIALS AND METHODS: Pigs underwent small bowel transplantation and were treated with tetrandrine or a vehicle. Blood and small bowel specimens were harvested at 1, 3, and 24 hours after reperfusion. Histopathologic analysis of the small bowel was assessed for tissue damage. Serum levels of tumor necrosis factor-alpha, interleukin-1beta (IL-1beta), and IL-6 were measured by enzyme-linked immunosorbent assay. Reverse-transcriptase polymerase chain reaction analysis was performed to analyze the expression of proinflammatory cytokines, and immunohistochemical analysis was used to study the expression of intercellular adhesion molecule-1 (ICAM-1) in the small bowel. Myeloperoxidase staining detected neutrophil infiltration in the small bowel and the number of myeloperoxidase positively stained cells was counted.
RESULTS: Pigs receiving small bowel transplantation had elevated serum proinflammatory cytokine levels. The transplanted small bowel showed mucosal damage, increased expression of proinflammatory cytokines and ICAM-1, and prominent neutrophil infiltration. Tetrandrine administration reduced mucosal damage, serum and tissue proinflammatory cytokine levels, ICAM-1 expression, and neutrophil accumulation in the transplanted small bowel.
CONCLUSIONS: Tetrandrine reduced the reperfusion injury in porcine intestinal transplantation during the first 24 hours after the procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944224     DOI: 10.1016/j.jpedsurg.2009.06.002

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase.

Authors:  Yu Wang; Xinjun Cai; Zhiheng Wu; Leilei Tang; Lingqun Lu; Yinyin Xu; Xiaogang Bao
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

Review 2.  The potential of tetrandrine as a protective agent for ischemic stroke.

Authors:  Yun Chen; Ya-Hui Tsai; Sheng-Hong Tseng
Journal:  Molecules       Date:  2011-09-16       Impact factor: 4.411

Review 3.  Influence of Growth Hormone and Glutamine on Intestinal Stem Cells: A Narrative Review.

Authors:  Yun Chen; Ya-Hui Tsai; Bor-Jiun Tseng; Sheng-Hong Tseng
Journal:  Nutrients       Date:  2019-08-17       Impact factor: 5.717

4.  Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1.

Authors:  Jun Wang; Ming Guo; Ruojia Ma; Maolin Wu; Yamei Zhang
Journal:  PeerJ       Date:  2020-05-07       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.